baber/WOPTO huggingface dataset:
Patent PT-1648244-E (PT)
Title: Method and device for the continuous coating of cores by means of a dragee-making apparatus
Inventor: NOHYNEK OLIVER
IPC: A23P20/13
Filed: 2004-07-30
Abstract: The dragee coating assembly (15), for coating cores, has at least one powered rotating drum (1) where they are covered by one or more coating material layers or are otherwise treated e.g. spraying or drying. The cores are delivered into the drum in small charges at the drum entry in cycles for processing in individual drum chambers (7-13). The chambers are formed by the longitudinal conveyor (3) carrying the charges and the inner drum wall. The products rotate constantly in the rotating drum without a longitudinal movement, and the conveyor transfers the products as required from one processing station to another, with a passage between chambers if required.
Patent PT-1656458-E (PT)
Title: Human autism susceptibility gene and uses thereof
Inventor: HAGER JORG
IPC: G01N33/50
Filed: 2004-08-20
Abstract: The present invention discloses the identification of a human autism susceptibility gene, which can be used for the diagnosis, prevention and treatment of autism and related disorders, as well as for the screening of therapeutically active drugs. The invention more specifically discloses that the SLC6A7 gene on chromosome 5 and certain alleles thereof are related to susceptibility to autism and represent novel targets for therapeutic intervention. The present invention relates to particular mutations in the SLC6A7 gene and expression products, as well as to diagnostic tools and kits based on these mutations. The invention can be used in the diagnosis of predisposition to, detection, prevention and/or treatment of Asperger syndrome, pervasive developmental disorder, mental retardation, anxiety, depression, attention deficit hyperactivity disorders, speech delay, epilepsy, metabolic disorder, immune disorder, bipolar disease and other psychiatric and neurological diseases.
Patent PT-1787516-E (PT)
Title: Sprout inhibiting composition
Inventor: VOORBRAAK PETRUS JOHANNES GERARDUS MARIA
IPC: A01N25/02
Filed: 2005-11-09
Abstract: The present invention relates to a sprout inhibiting composition comprising chlorpropham as an active compound and at least one lactate as a solvent, a method for preparing the sprout inhibiting composition and its use.
Patent PT-1571196-E (PT)
Title: Composition and method for improving the geotechnical characteristics of soils
Inventor: MANTEGAZZA GIOVANNI
IPC: C09K17/08
Filed: 2005-02-15
Abstract: Composition formed from a mixture of inorganic substances, to be used intimately mixed with the soil to improve its geomechanical characteristics.
Patent PT-1803440-E (PT)
Title: Pharmaceutical formulation comprising microcapsules of statins suspended in alkyl esters of polyunsaturated fatty asids (pufa)
Inventor: DUENA ANTONIO PARENTE
IPC: A61K9/16
Filed: 2005-10-13
Abstract: The invention relates to a pharmaceutical composition comprising a suspension consisting of an oil with a high concentration of alkyl esters of polyunsaturated fatty acids (PUFA) and to microcapsules comprising at least one polymer and a statin.
Patent PT-1951111-E (PT)
Title: Patient handling device including local status indication, one-touch fowler angle adjustment, and power-on alarm configuration
Inventor: BECKER DAVID TERRANCE
IPC: A61B5/00
Filed: 2006-11-07
Abstract: A patient handling device (20) includes a controller (44), with a plurality of sensors (54), control panels (68, 70, 72), and lamps (86, 88, 92) electrically connected to 10 the controller (44).-The patient handling device (20) records the normal/desired state of the various components when power is applied. When one of the components goes outside the normal/desired state, the controller (44) issues an alarm. This alarm includes illuminating a plurality of amber alert lamps (86, 88) which can normally be viewed by a user at any position around the outside of the patient handling device (20). The patient 15 handling device (20) also includes a position control (106). This control (106) restricts movement of an upper/fowler portion (32) of the patient handling device (20) in a certain range of angular positions, while permitting movement of the upper portion (32) outside the certain range. A normal lamp (92) is illuminated in the absence of an alarm.
Patent PT-2102091-E (PT)
Title: System and method for transporting inventory items
Inventor: FONTANA RICHARD R
IPC: B66F3/08
Filed: 2007-12-11
Abstract: An apparatus for transporting inventory items includes a housing, a drive module, a docking module, an elevating shaft, and a rotation module. The drive module is capable of propelling the apparatus in at least a first direction. The docking head is capable of coupling to or supporting an inventory holder. The rotation module is capable of inducing rotation in the housing relative to the elevating shaft. The elevating shaft connects to the docking head and is capable of raising the docking head when the housing is rotated relative to the elevating shaft.
Patent PT-2189282-E (PT)
Title: Use of silane-treated particles in laminates to improve clarity
Inventor: HINTZE MATS
IPC: B29B15/10
Filed: 2009-11-23
Abstract: The invention relates to a substrate having at least one decor layer or overlay being applied to at least one surface of the substrate, wherein hard particles are distributed over the decor layer or overlay for improving the abrasion resistance of the decor layer or overlay, wherein the hard particles have a coating containing a silane, preferably an aminosilane, providing a chargeable or electrically conductive surface for the coated particles. Furthermore, the invention relates to a process for the distribution of hard particles on a décor layer or overlay applicable to a substrate, comprising the steps of applying a thermosetting resin to the decor layer or overlay, providing hard particles having a coating containing a silane, preferably an aminosilane, providing a chargeable or electrically conductive surface for the coated particles, evenly distributing the coated particles on the surface of a feeding device, distributing the coated particles on the decor layer or overlay by releasing the evenly distributed particles from the feeding device by use of an electric field applied to the feeding device and coated particles thereon, and drying or curing the thermosetting resin.
Patent PT-2208784-E (PT)
Title: Cell proliferation inhibitors containing anti-glypican 3 antibody
Inventor: ABURATANI HIROYUKI
IPC: A61P35/00
Filed: 2002-06-21
Abstract: Cell-proliferation inhibitors contain anti-glypican 3 antibody as active ingredient, are new. An independent claim is also included for an antibody with cytotoxicity. ACTIVITY : Cytostatic. No Biological data is given. MECHANISM OF ACTION : None given in source material.
Patent PT-2323361-E (PT)
Title: Image sensor with interleaved image output
Inventor: TAY HIOK NAM
IPC: H04N9/07
Filed: 2003-02-20
Abstract: An image sensor (12) with a light reader circuit (16) coupled to a pixel array (14). The light reader (16) circuit retrieves a first image and a second image generated by the pixel array (14). The image sensor (12) may also include a memory controller (44) and/or data interface that transfers the first and second images to an external device in an interleaving manner.
Patent PT-2298214-E (PT)
Title: Illumination and laser source and method of transmitting illumination light and laser treatment light
Inventor: KANE JONATHAN S
IPC: A61B19/00
Filed: 2004-07-27
Abstract: A coaxial illuminated laser endoscopic probe and active numerical aperture control apparatus and method of use, succinctly known as an illumination and laser source, capable of selectively providing illumination light and laser treatment light through a single optical fiber. The apparatus and method is especially useful during ophthalmic surgery. The present art is capable of providing the aforesaid through an optical fiber of such small size that heretofore said fiber was only useable for laser treatment light only. The present art also, with its unique optical system, allows for two illumination light outputs from a single illumination source. The apparatus utilizes a phototoxicity risk card to calibrate the system to prior art or safe illumination levels since the unique optical system provides illumination light of greater intensity than the prior art.
Patent PT-636364-E (PT)
Inventor: GOWAN WALTER G JR
IPC: A61K9/20
Filed: 1994-07-27
Abstract: The present invention relates to a compressed pharmaceutical dosage form containing pharmaceutical particles coated with a taste-masking composition, a water-disintegratable, compressible carbohydrate and a binder. These components are dry blended and compressed into a dosage form, such as a tablet, having a hardness sufficient to cause the carbohydrate to disintegrate within 30 seconds after oral administration, thereby allowing the coated particles to be swallowed.
Patent PT-755447-E (PT)
Inventor: CAPRON ANDRE
IPC: C12N15/31
Filed: 1995-04-19
Abstract: A recombinant DNA containing a sequence (1) coding for a polypeptide heterologous to a filamentous haemagglutinin of Bordetella (Fha) fused within the reading frame to a sequence (2) located upstream from the first sequence. Sequence (2) codes for at least part of the Fha precursor, which part comprises at least the N-terminal region of a truncated mature Fha protein, which contains the interaction site of Fha and heparin and the secretion domain. This Fha protein is under the control of a promoter recognized by the cell polymerases of B. pertussis and is inserted into a B. pertussis cell culture, is expressed in the culture and excreted into the cell culture medium. The invention uses both the abilities of Bordetella and particularly B. pertussis to secrete or surface expose the heterologous polypeptide fused to the Fha portion corresponding to sequence (2), which does not appear to produce extracellular proteases, and the ease with which filamentous haemagglutinins can be isolated from other Bordetella proteins.
Patent PT-898682-E (PT)
Inventor: VANDEVOORDE JEAN-CLAUDE
IPC: E01F9/615
Filed: 1997-05-23
Abstract: The invention relates to a lighting device for signalling on and identification and marking of airport traffic areas, e.g. take-off runways, landing runways, taxiways and the like. Said device has light sources (1) for direct emission of visible light. To reduce energy consumption and maintenance costs for said lighting devices, it is proposed that the light sources take the form of semiconductor components.
Patent PT-915832-E (PT)
Inventor: STOLOWITZ MARK L
IPC: C12N15/09
Filed: 1997-07-24
Abstract: Boron compound complexing reagents, intermediate reagents of those reagents and methods of synthesizing these reagents are disclosed. These reagents, including those shown as General Formula (I) and General Formula (II) may be used, after further reactions described herein, to complex with boronic compounds, such as phenylboronic acid or derivatives thereof. Boron compound complexing reagents, boron compound complexes, and methods of synthesizing these reagents and complexes are disclosed. These reagents and complexes include those shown in General Formula (CIII), General formula (CIV), and General Formula (CVI). In one embodiment, the reagents of General formula (CIII) may be used to produce, after condensation with a bioactive species (BAS), the reagent of General Formula (CIV). The reagent of General Formula (CIV) may be used to form a complex with a boron compound, such as a complex shown in General Formula (CVI).
Patent PT-975582-E (PT)
Inventor: WAGNER PAUL
IPC: D21C9/10
Filed: 1998-03-23
Abstract: Preparation of imino-disuccinic acid alkali metal salts (I) involves: (i) reacting maleic anhydride (MA), alkali metal hydroxide (AMH), ammonia and water, in MA:AMH:NH3:H2O molar ratio of 2:0.1-4:1.1-6:5-30, at 70-170 degrees C and 1-80 bars for 0.1-100 hrs.; (ii) distilling off NH3 and water from the reaction mixture, with addition of water and 0-4 mol. AMH per 2 mols. MA initially used, at 50-170 degrees C and 0.1-50 bars over 0.1-50 hours, and (iii) adding water in an amount such that the obtained solution has a solids content of 5-60 wt.%.
Patent PT-1000990-E (PT)
Inventor: BECHTOLD WERNER
IPC: C09G1/08
Filed: 1999-11-16
Abstract: Organic solvent-free leather care material comprising an emulsion of wax, water and emulsifier, showing a maximum deformation ( gamma ) of 0.1 or less under a shear stress of 750 Pa applied for 5 minutes and a permanent deformation of not more than 50% of the max. deformation after relaxation for 5 minutes (both at 23 degrees C). An Independent claim is also included for a process for the production of this material by melting the wax and emulsifier(s) at elevated temperature, mixing the melt with water with stirring and then cooling the mixture.
Patent PT-1005588-E (PT)
Inventor: PITT RICHARD E
IPC: D21F1/48
Filed: 1999-06-17
Abstract: A method and apparatus for generating turbulence in stock to deflocculate the stock in an open surface forming section of a paper making machine comprises a dewatering box (2) providing vacuum assisted drainage and which has a set of dewatering elements that impart turbulence into relatively thick stock layers carried at machine operating speeds of equal up to about 400 m/min, for the production of paper products having a basis weight generally in excess of about 160 gsm. Each set of elements includes a lead-in element (5), at least one intermediate element (6, 7), and a trailing element (8). The path of the forming fabric (13) is deflected downwardly as it passes over the intermediate elements, which are inclined at an angle of from about 0 DEG  to about 10 DEG  from a plane defined by forming fabric supporting surfaces on the lead-in and riser elements. This vertical movement initiates turbulence and agitation in the stock, which acts both to deflocculate the stock and to diminish the possibility of sheet sealing. The apparatus is useable in combination with other known formation and drainage devices which are located either upstream or downstream to augment their performance with thicker, slower moving stock layers.
Patent PT-1126802-E (PT)
Inventor: HEATON KEITH PATRICK
IPC: A61F7/10
Filed: 1999-11-05
Abstract: An enclosure is described for containing a patient whose core temperature is to be cooled below normal body temperature, e.g. to reduce brain damage in patients suffering cardiac arrest. The enclosure comprises a base panel and one or more side panels attached to the base panel, the side panels being foldable over the patient to create an enclosure. Air conduits are provided on one or more panels with outlets positioned to direct cold air onto areas of the patient from which heat loss is particularly rapid.
Patent SG-64993-G (SG)
Title: Slow-release pharmaceutical composition
IPC: A61K9/22
Filed: 1993-05-18
Abstract: A slow-release pharmaceutical composition which comprises fumaric acid and/or DL-tryptophan in addition to one or more pharmaceutically active substances, and a process for preparing the same are disclosed. Among many organic acids and amino acids, fumaric acid and DL-tryptophan are remarkably useful for extending the duration of release of a pharmacologically active substance when fumaric acid, DL-tryptophan or both are used for the formulation of a pharmaceutical composition. The pharmaceutical composition may be in any solid form of formulations such as powder, granule, tablet, troche, capsule, suppository, etc., and may be used with practically all types of drugs.
Patent SG-89888-G (SG)
Title: Cross-linkable compositions for extrusion
IPC: C08K13/02
Filed: 1988-12-29
Abstract: A flame-retardant cross-linkable polymer composition for extrusion which is capable of producing non-porous products comprises: at least one flame-retardant filler of the class that evolve substantial amounts of bound water on heating at temperatures above a value Td that lies in the range 120 DEG -250 DEG  C.; a compatible ethyelene copolymer base in which the filler is dispersed; a hydrolysable unsaturated silane; and a free-radical grafting initiator having a half-life of less than 10 minutes at a temperature 25 DEG  C. below Td.
Patent IE-33916-L (IE)
Title: Hop extract
IPC: C12C3/00
Filed: 1970-01-08
Abstract: 1,236,731. Hop extracts. WATNEY COMBE REID & CO. Ltd. 7 Jan., 1970 [9 Jan., 1969], No. 1393/69. Heading C2C. [Also in Division C6] The alpha acids and beta acids are extracted from resinous hop material such as lupulin in the following process steps: (1) (optional) the hop material is given an initial wash with sodium or potassium hydrogen phosphate buffer solution of pH 4-9to extract selectively tannins and fatty acids, the temperature being kept low enough to avoid substantial dissolution of the alpha acid content of the hop fraction; (2) the alpha acids are then extracted with the aid of aqueous disodium or dipotassium hydrogen phosphate, or sodium or potassium citrate, at a pH in the range 7 to 9 and a temperature between 40‹ and 90‹ C.; and (3) the beta acids are extracted from the residue with a 0À2-2À0% by weight aqueous solution of sodium or potassium carbonate at a temperature in the range 25‹ to 100‹ C. Crystallization of the extracted alpha acids and beta acids may be promoted by the addition of acid, e.g. citric acid and gaseous carbon dioxide, respectively. The extractions may be performed by percolating alkali through a column of the lupulin-rich powder or by spraying the alkali on to the inside surface of a packed bed of the powder in a basket centrifuge. In both cases a filter aid (specified) should be included. The extracted alpha acids may be isomerized by boiling at atmospheric pressure for 2 hours at a pH of 9 (or longer at a lower pH). The extracted beta-acids may be oxidized to hulupones by gaseous oxygen at a temperature in the range 70-90‹ C.
[GB1236731A]
Patent IE-42240-L (IE)
Title: Foot exercise sandal
IPC: A43B7/26
Filed: 1976-01-16
Abstract: 1523971 Sandals SCHOLL (UK) Ltd 16 Jan 1976 [17 Jan 1975 22 March 1975] 01831/76 Heading A3B A foot exercise sandal comprises a sole 1 whose upper surface includes a ridge 3 extending in use, under the arches of at least the second to fourth toes, increasing in height to the second toe and dropping downwardly, at 4, in the region of the big and second toes to merge into a depression 5 for the ball of the big toe and a flattened portion for the toe, the sole upper surface being held in engagement with the sole of a wearer's foot by a strap 7 over the wearer's instep. The ridge 3 preferably extends from the outer side of the sole i.e. the little toe side and the downwardly extending portion 4 of the ridge may be at the outer face of the big toe, at the inner face of the second toe or between these toes. The ridge may become broader towards the portion 4. In one form, Fig. 3 the portion 4 is inclined to the vertical from its upper end to the flattened portion and in another form, Fig. 5 (not shown) the portion 4 has a rounded upper end which merges into a groove (4') at its lower end which slightly undercuts the ridge and merges with the depression 5. A shallow depression is preferably provided in front of the ridge 3 for the ends of the toes and a shallow heel depression and an arch corresponding to the foot arch are provided. The sole 1 is substantially rigid, is preferably of one piece and may have a heel. There is a covering 6 on the sole lower face to the bottom surface of which a coating e.g. non slip material may be applied. All or part of the sole upper face may carry a resilient layer. The strap 7 is positioned behind the ridge 3 and may be of two pieces, as shown, secured together by a buckle or press studs and may be permanently screwed or nailed to the sole or may be changeable for a different strap, then fixed by press studs to the sole.
[GB1523971A]
Patent IE-840274-L (IE)
Title: Improved synthesis of nizatidine
IPC: C07D277/22
Filed: 1984-02-06
Abstract: N-methyl-S-methyl-N min -[2-(2-dimethylamino-methylthiazol-4-ylmethylthio)et h yl]isothiourea is a novel intermediate useful for the preparation of nizatidine, a pharmaceutically valuable H2-receptor inhibitor, by reaction with nitromethane.
Patent IE-42478-L (IE)
Title: Pharmaceutical composition
IPC: C07C313/00
Filed: 1976-02-17
Abstract: The present invention relates to a new dimercaptoethylether derivative, namely 2,2'-bis(dimethylsulfoniumethyl)ether diiodide of the formula <IMAGE> +TR (I) prepared by reacting the 2,2'-bis(methylmercaptoethyl)ether of the formula H3C-S-CH2-CH2-O-CH2-CH2-S- CH3 (II) with methyl iodide.
[US4056634A]
Patent IE-41620-L (IE)
Title: Pharmaceutical preparation
IPC: A61K9/48
Filed: 1975-02-21
Abstract: 1506016 Encapsulated digoxin solution WELLCOME FOUNDATION Ltd 21 Feb 1975 [22 Feb 1974 19 March 1974] 7327/75 Heading A5B An orally ingestible digoxin preparation of improved properties comprises a capsule soluble in the stomach or duodenum contaming a solution of digoxin, the amount of digoxin in the capsule being less than that in a conventional tablet but nonetheless providing the same physiological effect as the conventional tablet. The capsule may contain 0.05-0.4mg. digoxin. Solvents specified include ethanol, isopropanol, propylene glycol, glycerol and polyethylene glycol of molecular weight 190-1000. The solvent may include up to 60 % water. The capsule may be a soft gelatin capsule including a plasticizer, preservative, colouring and/or opacifier.
[GB1506016A]
Patent IE-37399-L (IE)
Title: Salicylaldoximes; metal ligands
IPC: C07C239/00
Filed: 1973-03-12
Abstract: 1421766 Salicylaldoximes IMPERIAL CHEMICAL INDUSTRIES Ltd 8 March 1973 [21 March 1972] 13158/72 Heading C2C [Also in Division Cl] The invention comprises Salicylaldoximes of the formula wherein n is 1 or 2, one R is a branched nonyl group in the 5 position and when n is 2 the second R group is an alkyl group. The salicylaldoximes may be obtained by reacting a hydroxylamine (e.g. as hydrochloride in presence of sodium acetate) with the corresponding salicylaldehyde.
[GB1421766A]
Patent IE-790790-L (IE)
Title: N-(diaminophosphinyl) carboxamides.
IPC: A61P31/04
Filed: 1979-08-08
Abstract: A series of N-[diaminophosphinyl]arylcarboxamides are useful as inhibitors of the enzyme urease.
[US4182881A]
Patent IE-32886-L (IE)
Title: Cephalosporin derivatives
IPC: G01G21/04
Filed: 1969-06-13
Abstract: (A) Cephalosporin derivs. of formula (I), their non-toxic derivs. and salts and pharmaceutical compns. contng. them Ar=aromatic gp. X'=NH2 substd. NH2 OH, lower alkanoyloxy m=0 or 1 R'=lower alkyl. Esp. where Ar.CHX'.COOH belongs to the D-series and X'=NH2. (B) Cpds. of formula (IV) R2,3=lower alkyl. (C) Intermediates of formula (V). As antibacterial agents; some are active orally. (1) By acylation of (V). (2) From a 7-acylamino-3-(CH2P) cpd. where P=gp. replaceable by S(O)mR', followed if necessary by oxidn. of the S atom.
[CH535258A]
Patent FI-812013-L (FI)
Inventor: LIND ERWIN
IPC: G03G13/26
Filed: 1981-06-26
Abstract: This invention relates to an improvement in the process for the manufacture of printing forms and printed circuits by coating an electrically conductive support with an organic photoconductor layer and by charging, exposing, and developing the electrostatic image by means of a finely particulate toner, fixing and dissolving the layer away from the non-image areas by means of a decoating medium and, if appropriate, etching of the bared support surface, the improvement which comprises, for the purpose of coating, transferring the organic photoconductor layer on a temporary support to the electrically conductive support with the aid of heat and pressure.